Rating scales in depression: limitations and pitfalls

作者: Per Bech

DOI: 10.31887/DCNS.2006.8.2/PBECH

关键词: Depression (differential diagnoses)Rating scalePlaceboMEDLINEPsychiatryClinical psychologyEffect sizePsychologyAntidepressantPersonality Assessment InventoryClinical significance

摘要: Since the introduction of antidepressants to psychopharmacology in 1960s, Hamilton Depression Rating Scale (HAM-D) has been most frequently used rating scale for depression. When as a prediction outcome with antidepressants, HAM-D, by its total score, obtained limited use analogous Diagnostic and Statistical Manual Mental Disorders. 4th ed (DSM-IV) diagnosis major Most research devoted HAM-D discriminate between placebo active drugs or show dose-response relationship patients An improvement score during drug trial does not, however, itself qualify an antidepressant, because is not sufficient statistic. The problem statistical versus clinical significance when analyzing placebo-controlled trials, including relationship, outlined, recommendation effect size statistics.

参考文章(37)
P. Bech, Clinical Effects of Selective Serotonin Reuptake Inhibitors Clinical Pharmacology in Psychiatry. ,vol. 7, pp. 81- 93 ,(1989) , 10.1007/978-3-642-74430-3_9
Raymond W. Lam, Richard P. Swinson, Erin E. Michalak, Assessment Scales in Depression, Mania and Anxiety ,(2004)
Aaron T. Beck, Depression : clinical, experimental, and theoretical aspects Hoeber Medical Division, Harper & Row. ,(1967)
Per Bech, Pharmacological Treatment of Depressive Disorders: A Review John Wiley & Sons, Ltd. pp. 89- 160 ,(2003) , 10.1002/0470861665.CH2
Bech P, Kastrup M, Rafaelsen Oj, Mini-compendium of rating scales for states of anxiety depression mania schizophrenia with corresponding DSM-III syndromes. Acta Psychiatrica Scandinavica. ,vol. 326, pp. 1- 37 ,(1986)
O. Jacobsen, J. Vitger, T. G. Bolwig, P. Bech, L. F. Gram, E. Dein, Quantitative rating of depressive states. Acta Psychiatrica Scandinavica. ,vol. 51, pp. 161- 170 ,(1975) , 10.1111/J.1600-0447.1975.TB00002.X
Michael A Posternak, Mark Zimmerman, How accurate are patients in reporting their antidepressant treatment history Journal of Affective Disorders. ,vol. 75, pp. 115- 124 ,(2003) , 10.1016/S0165-0327(02)00049-6
Michael J. Detke, Yili Lu, David J. Goldstein, Robert K. McNamara, Mark A. Demitrack, Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression Journal of Psychiatric Research. ,vol. 36, pp. 383- 390 ,(2002) , 10.1016/S0022-3956(02)00060-2